An open label study to determine the efficacy and tolerability of tegaserod in the treatment of constipation-dominant irritable bowel syndrome (IBS-C)
- Resource Type
- Academic Journal
- Source
- Journal of Gastroenterology and Hepatology. Sep 01, 2003 18 Suppl 1:A78-A78
- Subject
- Language
- English
- ISSN
- 0815-9319